Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal nafarelin vs subcutaneous triptorelin for oocyte maturation trigger in ovarian stimulation
2024-516621-31-00Phase 4Authorised
- Sponsor
- Fundació Santiago Dexeus Font
- Start
- Sep 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in infertility comparing Intranasal nafarelin (Synarel) trigger with Subcutaneous triptorelin (Decapeptyl) trigger (2 arms). Primary endpoint: Number of MII oocytes retrieved. Planned start Sep 2026; status: authorised.
02
Drugs
nafarelintriptorelin
03
Conditions
infertility
Beyond the preview
Go deeper on 2024-516621-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516621-31-00.